CANADIAN NATURAL RESOURCES Ltd
CNQAbout the company
Canadian Natural Resources Limited engages in the acquisition, exploration, development, production, marketing, and sale of crude oil, natural gas, and natural gas liquids (NGLs) in Western Canada, the United Kingdom sector of the North Sea, and Offshore Africa. The company offers synthetic crude oil (SCO), mining bitumen, light and medium crude oil and NGLs, thermal bitumen, primary heavy crude oil and Pelican Lake heavy crude oil. Its midstream assets include two crude oil pipeline systems; and a 50% working interest in an 84-megawatt cogeneration plant at Primrose.
Investment snapshot
Positive
4
BUY / PASS
Neutral / negative
5 / 7
NEUTRAL / FAIL
Median fair value
$49.77
+0.0% vs price
Models with upside
2 / 17
Positive margin of safety
Strongest signal
6 of 10 pass — Dreman, Ackman, Neff +1 more object
Key risk
7 of 8 flag CNQ's growth — Graham, Lynch, Dreman +4 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #731 (Top 23.6%) | BUY | PASS | NEUTRAL | NEUTRAL | FAIL | NEUTRAL | PASS | FAIL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| Margin of Safety | -37.0% | N/A | N/A | -59.1% | N/A | N/A | N/A | +44.4% | +21.3% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow60% pass✓ 7✗ 5▾
6 of 10 pass — Dreman, Ackman, Neff +1 more object
Free Cash Flow Proxy$2.7B✓BuffettPositive and growingFCF Positive and Growing$4.4B✓LynchPositive and growingOperating Cash Flow$11.0B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=16.45%, ROA=11.78%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)9.4x✗Dreman< 8xP/E or FCF YieldP/E=13.2x✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive3/4 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency11/11 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Growth13% pass✓ 3✗ 10▾
7 of 8 flag CNQ's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -1.7% vs Rev: 13.9%✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency8/11 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-8.6%✗Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR16.4%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag CNQ's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio0.95✗Graham>= 2.0ROIC (3-5 yr avg)✗Buffett> 10%ROIC - WACC✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)18.6%✗Greenblatt> 25%Current Ratio Change YoY0.77 -> 0.95✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.42x -> 0.42x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities0.95✗Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of years - Valuation15% pass✓ 5✗ 23▾
11 of 13 flag CNQ's valuation — Graham, Lynch, Greenblatt +8 more
Net income / market capitalization+7.80%; #1037/6340 (top 16.4%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio3.2x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value9.3%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=9.3%, ROC=18.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS13.2x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)9.4x✗Dreman< 8xPrice / Book Value per Share3.2x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=13.2x, OE Yield=14.2%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=13.2x✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=13.2x, P/B=3.2x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low176% of trailing low ($28.27)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.3200; #3605/6449 (top 55.9%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS13.2x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share3.20x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.2796; #3417/5247 (top 65.1%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+7.34%; #2005/6202 (top 32.3%)✗OshaughnessyTop 10% of eligible cross-section - Profitability25% pass✓ 16✗ 19▾
12 of 16 flag CNQ's profitability — Graham, Buffett, Lynch +9 more
Net income / market capitalization+7.80%; #1037/6340 (top 16.4%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)8/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)8/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)22.0%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$2.7B✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE24.4%✓Lynch> 15%EBIT / Enterprise Value9.3%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=9.3%, ROC=18.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets11.78%✓PiotroskiROA > 0ROA Change YoY7.15% -> 11.78% (delta: +4.63%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=16.45%, ROA=11.78%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY✗PiotroskiImproved YoYPre-Tax Income / Revenue34.2%✓Dreman>= 8%Net Income / Shareholders' Equity24.4%✓Dreman> 12%Margin of SafetyP/E=13.2x, P/B=3.2x✓PabraiP/B < 1.5 or P/E < 15Return on Equity20.2% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value✗Marks>= 20% below intrinsic valuePositive Net Income Frequency8/11 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity24.4%✓Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+24.39%; #619/5226 (top 11.8%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0235; #1625/5884 (top 27.6%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years8/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts33% pass✓ 4✗ 8▾
Split decision: 7 FAIL · 5 NEUTRAL · 3 PASS · 1 BUY
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (3/9)✗LynchFAIL (3/7)✗GreenblattRank #731✓PiotroskiBUY (F-Score 8)✓DremanPASS (5/11)•MungerNEUTRAL (3/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)•MarksNEUTRAL (4/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked) - Debt & Leverage50% pass✓ 8✗ 7▾
6 of 12 pass — Graham, Lynch, Dreman +3 more object
Debt Levels0.36✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current AssetsLT Debt $11.8B vs NCA $-291.4M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.36, IC: 13.7x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.36✗Lynch< 0.33Cash - Long-term Debt$-11.3B✗LynchPositive preferredLT Debt / Total Assets Change19.24% -> 17.62%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities0.95✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.36✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDAIC=13.7x, D/EBITDA=0.7x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.36✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.3646; #2167/4210 (top 51.5%)✗AsnessTop 30% of eligible cross-section - Valuation models50% pass✓ 2✗ 2▾
Models split on CNQ at $49.75 — fair values range $31.27–$89.41
Graham fair value$36.32✗Graham-37.0% margin vs $49.75Greenblatt fair value$31.27✗Greenblatt-59.1% margin vs $49.75Pabrai fair value$89.41✓Pabrai+44.4% margin vs $49.75Akre fair value$63.22✓Akre+21.3% margin vs $49.75
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 1.0% of shares last year, 2.9% over two.
- Buybacks
- $1.1B
- Dividends
- $3.6B
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|
| Market Cap | $101.2Bcurrent | $61.6Best. | $31.6Best. | $29.8Best. | $24.0Best. |
| Revenue | $28.3B↑14% | $24.8B↓9% | $27.2B↓13% | $31.2B↑32% | $23.6B |
| Operating Income | -- | -- | -- | -- | -- |
| Net Income | $7.9B↑86% | $4.3B↓32% | $6.2B↓23% | $8.1B↑34% | $6.0B |
| EPS (Diluted) | $3.77↑90% | $1.99↓65% | $5.65↓20% | $7.02↑39% | $5.07 |
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| ROE | 24.4%↑58% | 15.5%↓25% | 20.7%↓28% | 28.6%↑38% | 20.7% |
| Total Debt | $11.8B↓1% | $11.9B↑60% | $7.4B↓12% | $8.4B↓21% | $10.7B |
| Shareholders' Equity | $32.4B↑18% | $27.5B↓9% | $30.1B↑7% | $28.2B↓3% | $29.0B |
| Current Ratio | 0.95↑24% | 0.77↓20% | 0.96↑18% | 0.82↑2% | 0.80 |
| Debt / Equity | 0.36↓16% | 0.43↑76% | 0.25↓18% | 0.30↓19% | 0.37 |
| Operating Cash Flow | $11.0B↑18% | $9.3B | $9.3B↓35% | $14.3B↑26% | $11.4B |
| Free Cash Flow | -- | -- | -- | -- | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Petroleum and Natural Gas
CNQ vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TotalEnergies SETTE | $199.0B | $90.74 | $201.2B | $13.1B | 11.4% | 0.49 | — | 0.97 | 4/9 | 4/9 | 1/7 | 0/3 | F-Score 4 | 6/11 |
| CONOCOPHILLIPSCOP | $168.2B | $142.28 | $58.9B | $8.0B | 12.4% | 0.36 | — | 1.30 | 2/9 | 3/9 | 3/7 | 0/3 | F-Score 7 | 6/11 |
| BP PLCBP | $117.7B | $45.70 | $192.5B | $55.0M | 0.1% | 1.09 | 6.6% | 1.26 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 2/11 |
| SUNCOR ENERGY INCSU | $80.5B | $69.92 | $38.2B | $4.3B | 13.1% | 0.22 | — | 1.39 | 2/9 | 2/9 | 2/7 | 0/3 | F-Score 4 | 6/11 |
| CENOVUS ENERGY INC.CVE | $52.6B | $29.08 | $36.3B | $2.9B | 12.4% | 0.35 | — | 1.57 | 1/9 | 1/9 | 3/7 | 0/3 | F-Score 5 | 5/11 |
| WOODSIDE ENERGY GROUP LTDWDS | $40.1B | $21.08 | $13.0B | $2.7B | 7.6% | 0.33 | 30.0% | 1.59 | 3/9 | 4/9 | 0/7 | 0/3 | F-Score 4 | 7/11 |
| EXPAND ENERGY CorpEXE | $20.4B | $88.53 | $12.1B | $1.8B | 9.8% | 0.27 | 20.4% | 1.01 | 2/9 | 5/9 | 3/7 | 1/3 | F-Score 7 | 7/11 |
| YPF SOCIEDAD ANONIMAYPF | $14.9B | $37.90 | $18.4B | $826.0M | -7.6% | 0.98 | 9.4% | 0.87 | 2/9 | 1/9 | 1/7 | 0/3 | F-Score 4 | 3/11 |